Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from inter
CAS Number:
[1855925-27-7]
* VAT and and shipping costs not included. Errors and price changes excepted